Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,359Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Diprosone

02 3Diprospan

03 5Dovobet

PharmaCompass

01

Brand Name : Dovobet

Betamethasone Dipropionate

arrow
American Pharma Summit
Not Confirmed

Brand Name : Dovobet

arrow
American Pharma Summit
Not Confirmed

Betamethasone Dipropionate

Main Therapeutic Indication : Dermatology

Currency : USD

2020 Revenue in Millions : 65

2019 Revenue in Millions : 65

Growth (%) : 1

blank

02

Brand Name : Diprosone

Betamethasone Dipropionate

arrow
American Pharma Summit
Not Confirmed

Brand Name : Diprosone

arrow
American Pharma Summit
Not Confirmed

Betamethasone Dipropionate

Main Therapeutic Indication : Dermatology

Currency : USD

2021 Revenue in Millions : 87

2020 Revenue in Millions : 83

Growth (%) : 5

blank

03

Brand Name : Diprospan

Betamethasone Dipropionate

arrow
American Pharma Summit
Not Confirmed

Brand Name : Diprospan

arrow
American Pharma Summit
Not Confirmed

Betamethasone Dipropionate

Main Therapeutic Indication : Rheumatology

Currency : USD

2021 Revenue in Millions : 125

2020 Revenue in Millions : 118

Growth (%) : 6

blank

04

Brand Name : Dovobet

Betamethasone Dipropionate

arrow
American Pharma Summit
Not Confirmed

Brand Name : Dovobet

arrow
American Pharma Summit
Not Confirmed

Betamethasone Dipropionate

Main Therapeutic Indication : Dermatology

Currency : USD

2021 Revenue in Millions : 61

2020 Revenue in Millions : 65

Growth (%) : 4

blank

05

Brand Name : Dovobet

Betamethasone Dipropionate

arrow
American Pharma Summit
Not Confirmed

Brand Name : Dovobet

arrow
American Pharma Summit
Not Confirmed

Betamethasone Dipropionate

Main Therapeutic Indication : Dermatology

Currency : USD

2022 Revenue in Millions : 59

2021 Revenue in Millions : 61

Growth (%) : -3

blank

06

Brand Name : Diprospan

Betamethasone Dipropionate

arrow
American Pharma Summit
Not Confirmed

Brand Name : Diprospan

arrow
American Pharma Summit
Not Confirmed

Betamethasone Dipropionate

Main Therapeutic Indication : Rheumatology

Currency : USD

2022 Revenue in Millions : 122

2021 Revenue in Millions : 125

Growth (%) : -2

blank

07

Brand Name : Dovobet

Betamethasone Dipropionate

arrow
American Pharma Summit
Not Confirmed

Brand Name : Dovobet

arrow
American Pharma Summit
Not Confirmed

Betamethasone Dipropionate

Main Therapeutic Indication : Dermatology

Currency : USD

2023 Revenue in Millions : 53

2022 Revenue in Millions : 59

Growth (%) : 1

blank

08

Brand Name : Diprospan

Betamethasone Dipropionate

arrow
American Pharma Summit
Not Confirmed

Brand Name : Diprospan

arrow
American Pharma Summit
Not Confirmed

Betamethasone Dipropionate

Main Therapeutic Indication : Rheumatology

Currency : USD

2023 Revenue in Millions : 91

2022 Revenue in Millions : 122

Growth (%) : -25

blank

09

Brand Name : Dovobet

Betamethasone Dipropionate

arrow
American Pharma Summit
Not Confirmed

Brand Name : Dovobet

arrow
American Pharma Summit
Not Confirmed

Betamethasone Dipropionate

Main Therapeutic Indication : Dermatology

Currency : USD

2019 Revenue in Millions : 63

2018 Revenue in Millions : 55

Growth (%) : 15

blank